NCT04984993 - Clinical Investigation Using MED3000 Gel or Tadalafil Tablets in the Treatment of Erectile Dysfunction | Biotech Hunter

Enrollment

116

Participants

Timeline

Start Date

September 14, 2021

Primary Completion Date

July 13, 2022

Study Completion Date

July 13, 2022

Conditions

Erectile Dysfunction

Interventions

DEVICE

MED3000 (Male)

Gel formulation

DRUG

Tadalafil 5mg (Male)

Tablets

DEVICE

MED3000 (Female)

Gel formulation

DRUG

Tadalafil 5mg (Female)

Tablets

Trial Locations (18)

1000

"Medical Center INTERMEDICAООD", Sofia

2600

"Medical Center AsklepiiOOD", Dupnitsa

3700

Rustavi N2 Medical Diagnostic Center, Rustavi

4002

"ЕТ Аssoc. Prof. Stefan Popov - Individual Practice for Specialized Outhospital medical care for Neurology and Pscyhiatry", Plovdiv

4600

"Jsc Evex Clinics", Kutaisi

7500

"MHAT SilistraAD", Silistra

21205

Johns Hopkins University, Baltimore

Unknown

UMHAT Plovdiv AD, Plovdiv

LTD Health, Batumi

0112

"Clinic GIDMEDI", Tbilisi

0160

"JSC Evex clinics", Tbilisi

0162

Raymann LLC, Tbilisi

40-065

The Mikolowska Medical Center, Katowice

40-611

Provita Sp. z o.o., Katowice

30-074

Medistica Osteomed, Krakow

20-93

PROVITA Specialised Gynecology and Sexology Practice, Lublin

05-077

Sexology and Pathology of Intercourse Clinic, Warsaw

53-532

Ryszard Smoliński's Medical Cabinet, Wroclaw